Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Gross Margin % is 20.89% as of Feb. 2026, which is 5% above its 10-year median of 19.92. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 630 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 82.54% on this metric.
CSMYF's Gross Margin % is ranked worse than 82.54% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.01
vs CSMYF: 20.95
COSMOS Pharmaceutical had a gross margin of 20.89% for the quarter that ended in Feb. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for COSMOS Pharmaceutical was 0.80% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
COSMOS Pharmaceutical had a gross margin of 20.89% for the quarter that ended in Feb. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
COSMOS Pharmaceutical Gross Margin % Related Terms
COSMOS Pharmaceutical Gross Margin % Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
COSMOS Pharmaceutical (CSMYF) has a Gross Margin % of 20.89% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on COSMOS Pharmaceutical and its competitors. This is near median its historical median of 19.92. Over the past decade, COSMOS Pharmaceutical's Gross Margin % has ranged from 19.42 to 21.09. According to the industry distribution chart, COSMOS Pharmaceutical ranks #520 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 82.5%.
Is COSMOS Pharmaceutical's Gross Margin % too high?
COSMOS Pharmaceutical's current Gross Margin % of 20.89% is near median its 10-year median of 19.92. Over the past 10 years, this metric has ranged from a low of 19.42 to a high of 21.09. The Healthcare Providers & Services industry median Gross Margin % is 40.01. COSMOS Pharmaceutical's value of 20.89% is 47.8% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #520 out of 630 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #520 out of 630 companies for Gross Margin %. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Gross Margin % is 40.01. COSMOS Pharmaceutical's value of 20.89% is 47.8% below this benchmark. Historically, COSMOS Pharmaceutical's own Gross Margin % has ranged from 19.42 to 21.09 over the past decade. While the company's 10-year median is 19.92 vs. the industry median of 40.01, COSMOS Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.01, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Gross Margin % of 20.89% is 47.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Gross Margin % is 20.89%, which is near median its own 10-year median of 19.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Gross Margin % is 20.89%, which is near median its 10-year median of 19.92 and 47.8% below the Healthcare Providers & Services industry median of 40.01. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Gross Margin % is 20.89% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Gross Margin %: 20.89% (near median its 10-year median of 19.92)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 47.8% below the Healthcare Providers & Services median (#520 of 630)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
